Researchers from Graz test corona drugs on SARS-CoV-2 virus samples

The Austrian Center of Industrial Biotechnology (acib), the Medical University of Graz and the Graz biotech company Innophore are testing possible drugs for theirs effect against SARS-CoV-2 pathogens in Austria’s safest laboratory at the BBMRI.at partner Med Uni Graz.

Aim is to build up a preclinical database of active ingredients and to lead viral drugs to clinical application more quickly.